$7.53
-0.50-6.23%
In chiusura: Nov 19, 4:00 PM EST
$7.53
N/A
Post-mercato: 4:24 PM EST

Capricor Therapeutics (CAPR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $-0.73 | $-0.45 | -62.2 % |
| Q2 | Aug 13, 2026 | $-0.70 | $-0.58 | -20.7 % |
| Q1 | May 12, 2026 | $-0.59 | $-0.54 | -9.26 % |
| Q4 | Mar 12, 2026 | $-0.62 | $-0.53 | -17.0 % |
Quarterly Revenue (Billions)
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 10, 2026 | $0 | $10.40M | -100.0 % |
| Q1 | May 12, 2026 | $0 | $25.20M | -100.0 % |
| Q4 | Mar 12, 2026 | $0 | $1.68M | -100.0 % |
| Q3 | Nov 10, 2025 | $0 | $1.25M | -100.0 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.45 | $-0.58 | $-0.54 | $-0.53 |
| Actual | $-0.73 | $-0.70 | $-0.59 | $-0.62 |
| Surprise | -62.2% | -20.7% | -9.26% | -17.0% |
| Revenue | ||||
| Estimate | $10.4M | — | $25.2M | $1.7M |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | — | -100.0% | -100.0% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.41 | $-0.47 | $-0.43 | $-0.33 |
| Revenue | ||||
| Consensus | $16.4M | $9.5M | — | — |